| If
you cannot view the eLetter, or the links do not work, you can read
it on the Web at
http://www.scleroderma.org/e-letters/eLetter_126.htm.
If someone has forwarded this eLetter to you, and you
wish to subscribe to this FREE weekly publication, go to http://www.scleroderma.org/e_letter_signup.shtm.
|
|
Email
Us
Free
Info Packet
Calendar
Magazine
Chat
Medical
Archive
Support
SF
SF
Store
SF
Home Page
Advocacy
Alert!
As
you probably know, a new PH medication was approved by the FDA in
June, 2005. The new medication, Revatio™, has the same ingredients
as Viagra™, the erectile dysfunction drug. However, Revatio™
has been tested and approved specifically for use in treating pulmonary
hypertension.
|
|
| |
|
 This
cycle's Peer Review Committee carefully reviewed many outstanding
proposals from scientists in the U.S., Italy, France, Spain,
and Denmark. They selected the top scoring grants based on
the National Institutes of Health (NIH) criteria.
|
 |
|
On
January 20, the Centers for Medicare and Medicaid Services
(CMS) sent a directive to insurers that offer Medicare prescription
drug benefit plans, instructing them that they are required
to provide beneficiaries a 30-day emergency supply of any
drugs they were taking before the Medicare prescription drug
benefit began Jan. 1, the "New York Times" reports. |
|
|
POZEN
Inc. presented key data from its PN 100 proof-of-concept study
during the American College of Gastroenterology Annual Meeting
in Honolulu, Hawaii on November 2, 2005. PN 100 is a fixed
combination of the proton pump inhibitor (PPI) lansoprazole
and the NSAID naproxen. Dr. James Alexander, POZEN's senior
vice president of product development and chief medical officer,
stated that the key finding of this trial is that PN 100 appears
to work very well as evidenced by the fact that it significantly
reduced gastric damage due to naproxen during the study period. |
|
|
Bosentan
temporarily improves functional capacity in patients with
pulmonary arterial hypertension secondary to systemic sclerosis
(SSc-PAH), including patients with restrictive lung disease,
but pulmonary hemodynamics and pulmonary function remain stable,
according to a report in the January issue of the "Journal
of Rheumatology."
(may require registration to Medscape)
|
|
|
In
addition to our nationwide network of Chapters
and Support
Groups, we offer you electronic ways to connect with other
people. |
|
|
Feb. 5 (Sun.): Michigan
Chapter Patient Education Meeting (Southfield, Mich.)
|
|
|
|
